These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 20155615)

  • 1. Lycopene effects contributing to prostate health.
    Wertz K
    Nutr Cancer; 2009; 61(6):775-83. PubMed ID: 20155615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lycopene: modes of action to promote prostate health.
    Wertz K; Siler U; Goralczyk R
    Arch Biochem Biophys; 2004 Oct; 430(1):127-34. PubMed ID: 15325920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells.
    Karas M; Amir H; Fishman D; Danilenko M; Segal S; Nahum A; Koifmann A; Giat Y; Levy J; Sharoni Y
    Nutr Cancer; 2000; 36(1):101-11. PubMed ID: 10798222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy.
    Kucuk O; Sarkar FH; Sakr W; Djuric Z; Pollak MN; Khachik F; Li YW; Banerjee M; Grignon D; Bertram JS; Crissman JD; Pontes EJ; Wood DP
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):861-8. PubMed ID: 11489752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lycopene in the prevention of prostate cancer.
    Dahan K; Fennal M; Kumar NB
    J Soc Integr Oncol; 2008; 6(1):29-36. PubMed ID: 18302908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lycopene reduced gene expression of steroid targets and inflammatory markers in normal rat prostate.
    Herzog A; Siler U; Spitzer V; Seifert N; Denelavas A; Hunziker PB; Hunziker W; Goralczyk R; Wertz K
    FASEB J; 2005 Feb; 19(2):272-4. PubMed ID: 15545302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lycopene induces cell growth inhibition by altering mevalonate pathway and Ras signaling in cancer cell lines.
    Palozza P; Colangelo M; Simone R; Catalano A; Boninsegna A; Lanza P; Monego G; Ranelletti FO
    Carcinogenesis; 2010 Oct; 31(10):1813-21. PubMed ID: 20699249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth inhibitory efficacy of lycopene and β-carotene against androgen-independent prostate tumor cells xenografted in nude mice.
    Yang CM; Yen YT; Huang CS; Hu ML
    Mol Nutr Food Res; 2011 Apr; 55(4):606-12. PubMed ID: 21462328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
    Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
    Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lycopene supplementation inhibits lung squamous metaplasia and induces apoptosis via up-regulating insulin-like growth factor-binding protein 3 in cigarette smoke-exposed ferrets.
    Liu C; Lian F; Smith DE; Russell RM; Wang XD
    Cancer Res; 2003 Jun; 63(12):3138-44. PubMed ID: 12810641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lycopene and soy isoflavones in the treatment of prostate cancer.
    Vaishampayan U; Hussain M; Banerjee M; Seren S; Sarkar FH; Fontana J; Forman JD; Cher ML; Powell I; Pontes JE; Kucuk O
    Nutr Cancer; 2007; 59(1):1-7. PubMed ID: 17927495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lycopene and vitamin E interfere with autocrine/paracrine loops in the Dunning prostate cancer model.
    Siler U; Barella L; Spitzer V; Schnorr J; Lein M; Goralczyk R; Wertz K
    FASEB J; 2004 Jun; 18(9):1019-21. PubMed ID: 15084515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of insulin-like growth factor-I for prostate cancer therapies.
    Kojima S; Inahara M; Suzuki H; Ichikawa T; Furuya Y
    Int J Urol; 2009 Feb; 16(2):161-7. PubMed ID: 19183230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lycopene and prostate cancer.
    Barber NJ; Barber J
    Prostate Cancer Prostatic Dis; 2002; 5(1):6-12. PubMed ID: 15195123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cis-trans lycopene isomers, carotenoids, and retinol in the human prostate.
    Clinton SK; Emenhiser C; Schwartz SJ; Bostwick DG; Williams AW; Moore BJ; Erdman JW
    Cancer Epidemiol Biomarkers Prev; 1996 Oct; 5(10):823-33. PubMed ID: 8896894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models.
    Miyake H; Pollak M; Gleave ME
    Cancer Res; 2000 Jun; 60(11):3058-64. PubMed ID: 10850457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lycopene differentially induces quiescence and apoptosis in androgen-responsive and -independent prostate cancer cell lines.
    Ivanov NI; Cowell SP; Brown P; Rennie PS; Guns ES; Cox ME
    Clin Nutr; 2007 Apr; 26(2):252-63. PubMed ID: 17337101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are lycopene metabolites metabolically active?
    Ford NA; Erdman JW
    Acta Biochim Pol; 2012; 59(1):1-4. PubMed ID: 22428115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of lycopene supplementation in Tobago men with high prostate cancer risk.
    Bunker CH; McDonald AC; Evans RW; de la Rosa N; Boumosleh JM; Patrick AL
    Nutr Cancer; 2007; 57(2):130-7. PubMed ID: 17571945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survivin mediates resistance to antiandrogen therapy in prostate cancer.
    Zhang M; Latham DE; Delaney MA; Chakravarti A
    Oncogene; 2005 Apr; 24(15):2474-82. PubMed ID: 15735703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.